Market Overview

Morning Market Losers

Related PPHM
New Translational Data Highlights Bavituximab's Ability to Induce Signs of Immune Activation in Lung Cancer Tumor Samples With Negative PD-L1 Expression
US Stock Futures Tumble, China's Shanghai Plunges 8.5%
Related QCOR
There's A Reason Mallinckrodt Continues To Disclose A Protracted, Multi-Agency Probe Of Recently-Acquired Questcor Pharmaceuticals
Kase Fund's Top 10 Stocks In 2015

Peregrine Pharmaceuticals (NASDAQ: PPHM) fell 74.58% to $1.37 at 10:55 am. Peregrine Pharmaceuticals reported that it discovered major discrepancies in its Phase II trial data of bavituximab.

Questcor Pharmaceuticals (NASDAQ: QCOR) shares dipped 31.50% to $20.64. Analysts at ThinkEquity downgraded Questcor from “buy” to “hold.”

Daegis (NASDAQ: DAEG) dropped 19.08% to $1.40. Daegis' trailing-twelve-month ROE is -110.48%.

Dialogic (NASDAQ: DLGC) shares lost 19% to $2.60. Dialogic shares have dipped 72.56% over the past 52 weeks, while the S&P 500 index has gained 25.57% in the same period.

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets


Related Articles (DAEG + DLGC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters